A major 2026 trend in the pet dermatology sector is the total overhaul of "Drug Delivery Systems" to improve owner compliance. In 2026, the market is identifying "Chewable Therapeutic Tablets" as a critical value-shifter for the Canine Atopic Dermatitis Market, with Zoetis’s Apoquel Chewable leading a surge in flavor-enhanced medications. This 2026 movement is critical because nearly 40%...